RxDoctor Payments Data

Dennis Shults

Family Medicine · Brea, CANPI 1043370026

Payments from drug & device makers

$287,262in general payments, 2019–2025

Across 132 payments — averaging $2176.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$287K
  • Smith+Nephew$125
  • Novo Nordisk$32

What the payments were for

  • Consulting fees$285,62599%
  • Travel & lodging$1,0040%
  • Food & beverage$1250%
  • Education$5070%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.130$287,104
Smith+Nephew1$125
Novo Nordisk1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$287,262 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Other family medicine in Brea

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →